Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms

Antimicrobial Agents and Chemotherapy
Priya UppuluriDavid R Andes

Abstract

Calcineurin is a Ca2+-calmodulin-activated serine/threonine-specific protein phosphatase that governs multiple aspects of fungal physiology, including cation homeostasis, morphogenesis, antifungal drug susceptibility, and virulence. Growth of Candida albicans planktonic cells is sensitive to the calcineurin inhibitors FK506 and cyclosporine A (CsA) in combination with the azole antifungal fluconazole. This drug synergism is attributable to two effects: first, calcineurin inhibitors render fluconazole fungicidal rather than simply fungistatic, and second, membrane perturbation by azole inhibition of ergosterol biosynthesis increases intracellular calcineurin inhibitor concentrations. C. albicans cells in biofilms are up to 1,000-fold more resistant to fluconazole than planktonic cells. In both in vitro experiments and in an in vivo rat catheter model, C. albicans cells in biofilms were resistant to individually delivered fluconazole or calcineurin inhibitors but exquisitely sensitive to the combination of FK506-fluconazole or CsA-fluconazole. C. albicans strains lacking FKBP12 or expressing a dominant FK506-resistant calcineurin mutant subunit (Cnb1-1) formed biofilms that were resistant to FK506-fluconazole but susceptible to C...Continue Reading

References

Jan 1, 1987·Critical Reviews in Microbiology·H Vanden BosscheP Marichal
Jan 1, 1985·Current Topics in Medical Mycology·H Vanden Bossche
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R P Wenzel
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E Dismukes
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·O MarchettiD Sanglard
Sep 12, 2000·The Journal of Antimicrobial Chemotherapy·G S Baillie, L J Douglas
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·G RamageJ L López-Ribot
Feb 16, 2002·The EMBO Journal·M Cristina CruzJoseph Heitman
Oct 9, 2002·Molecular Microbiology·Thomas EdlindJoseph Nickels
Jun 11, 2003·Eukaryotic Cell·Jill R BlankenshipJoseph Heitman
Aug 23, 2003·Infection and Immunity·Teresa BaderJoachim Morschhäuser
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Stefano P BachmannJosé L López-Ribot
Aug 10, 2005·Eukaryotic Cell·Mathias L RichardAaron P Mitchell
Aug 23, 2005·Infection and Immunity·Jill R Blankenship, Joseph Heitman
Feb 14, 2006·Molecular Microbiology·Mahir KarababaDominique Sanglard
Jul 13, 2006·Eukaryotic Cell·William J SteinbachJohn R Perfect
Aug 23, 2006·Antimicrobial Agents and Chemotherapy·Chiatogu OnyewuJoseph Heitman
Nov 30, 2006·Antimicrobial Agents and Chemotherapy·Jeniel NettDavid Andes
May 2, 2007·The Journal of Infectious Diseases·Jeniel NettDavid Andes
May 16, 2007·Antimicrobial Agents and Chemotherapy·Palani PerumalW LaJean Chaffin
May 17, 2007·Nature Reviews. Microbiology·William J SteinbachJoseph Heitman

❮ Previous
Next ❯

Citations

Sep 17, 2009·Applied Microbiology and Biotechnology·Miao DuoDacheng Ren
Aug 27, 2013·Current Genetics·Lotte Mathé, Patrick Van Dijck
Feb 16, 2010·Odontology·Masakazu NiimiRichard D Cannon
Oct 26, 2013·International Journal of Antimicrobial Agents·Alba A Chavez-DozalSamuel A Lee
May 26, 2009·Revista iberoamericana de micología·Guillermo QuindósElena Eraso
Apr 10, 2013·Asian Pacific Journal of Tropical Biomedicine·N B DhayanithiN Sivakumar
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Camile P Semighini, Joseph Heitman
Apr 27, 2010·The Journal of Infectious Diseases·Aspasia KatragkouEmmanuel Roilides
May 20, 2009·Antimicrobial Agents and Chemotherapy·Eric DannaouiOlivier Lortholary
Nov 7, 2012·Antimicrobial Agents and Chemotherapy·Ilka Tiemy KatoMartha Simões Ribeiro
Apr 16, 2009·Clinical Microbiology Reviews·Richard D CannonBrian C Monk
Jul 8, 2010·Infection and Immunity·Jeniel E NettDavid R Andes
Oct 2, 2009·Journal of Clinical Microbiology·Priya UppuluriJose L Lopez-Ribot
Jun 27, 2013·MBio·Anand SrinivasanAnand K Ramasubramanian
Jun 8, 2011·Microbiology and Molecular Biology Reviews : MMBR·Rebecca S ShapiroLeah E Cowen
Jun 22, 2012·Canadian Journal of Microbiology·J J C SidrimM F G Rocha
Apr 21, 2012·International Journal of Microbiology·Gordon RamageCraig Williams
Oct 6, 2012·Annals of Clinical Microbiology and Antimicrobials·Ravikumar B ShindeSankunny M Karuppayil
Aug 7, 2012·Biological & Pharmaceutical Bulletin·Wenqiang ChangHongxiang Lou
Mar 28, 2013·PloS One·François L MayerBernhard Hube
Sep 21, 2011·PLoS Pathogens·Nicole RobbinsLeah E Cowen
Sep 26, 2013·Future Microbiology·Heather T TaffDavid R Andes
Feb 11, 2014·Expert Review of Anti-infective Therapy·Jeniel E Nett
Jun 14, 2015·Expert Review of Anti-infective Therapy·Kaat De CremerKatrijn De Brucker
Jun 7, 2013·Expert Opinion on Drug Discovery·Christopher G Pierce, Jose L Lopez-Ribot
Sep 10, 2013·Current Opinion in Pharmacology·Christopher G PierceJosé L López-Ribot
Nov 1, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Aijaz AhmadNikhat Manzoor
Apr 10, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·K AmberM Nikhat
Dec 27, 2015·Medical Mycology·Mohammad T Albataineh, David Kadosh
Apr 1, 2016·Scientific Reports·Farazul HaqueMani Shankar Bhattacharyya
Jul 17, 2010·Journal of Medical Microbiology·Aijaz AhmadNikhat Manzoor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.